182 related articles for article (PubMed ID: 36402613)
21. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
22. Top advances of the year: Hepatobiliary cancers.
Coffman-D'Annibale KL; Greten TF
Cancer; 2023 Apr; 129(8):1149-1155. PubMed ID: 36692965
[TBL] [Abstract][Full Text] [Related]
23. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
Wu LM; Zhang LL; Chen XH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
25. Precision Oncology in Hepatopancreatobiliary Cancer Surgery.
Newhook TE; Tsai S; Meric-Bernstam F
Surg Oncol Clin N Am; 2024 Apr; 33(2):343-367. PubMed ID: 38401914
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.
Levolger S; van Vugt JL; de Bruin RW; IJzermans JN
Br J Surg; 2015 Nov; 102(12):1448-58. PubMed ID: 26375617
[TBL] [Abstract][Full Text] [Related]
27. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
McNamara MG
Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
[No Abstract] [Full Text] [Related]
28. [Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].
Voesch S; Bitzer M; Malek N
Radiologe; 2022 Mar; 62(3):200-204. PubMed ID: 35147708
[TBL] [Abstract][Full Text] [Related]
29. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.
Robertson JM; Lawrence TS; Dworzanin LM; Andrews JC; Walker S; Kessler ML; DuRoss DJ; Ensminger WD
J Clin Oncol; 1993 Jul; 11(7):1286-93. PubMed ID: 8391066
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.
Mulder K; Koski S; Scarfe A; Chu Q; King K; Spratlin J
Oncotarget; 2010 Nov; 1(7):515-529. PubMed ID: 21317448
[TBL] [Abstract][Full Text] [Related]
31. The challenge of treating older patients with pancreaticobiliary malignancies.
Corrigan LR; Bracken-Clarke DM; Horgan AM
Curr Probl Cancer; 2018; 42(1):59-72. PubMed ID: 29459178
[TBL] [Abstract][Full Text] [Related]
32. Portal embolization in various types of liver: novel variables to predict hypertrophy.
Kaido T; Arii S; Shimada Y; Mori A; Imamura M
Hepatogastroenterology; 2003; 50(49):140-5. PubMed ID: 12630010
[TBL] [Abstract][Full Text] [Related]
33. Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
Leigh N; Solomon D; Pletcher E; Labow DM; Magge DR; Sarpel U; Golas BJ
World J Surg Oncol; 2020 Jun; 18(1):124. PubMed ID: 32527272
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics of multiple primary cancers in hepatobiliary and pancreas malignancies.
Nanashima A; Kondo H; Nakashima M; Abo T; Arai J; Ishii M; Hidaka S; Kunizaki M; To K; Takeshita H; Yamasaki N; Tsuchiya T; Nagayasu T
Anticancer Res; 2015 Feb; 35(2):1073-83. PubMed ID: 25667496
[TBL] [Abstract][Full Text] [Related]
35. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of HPB malignancy in the elderly.
Pericleous M; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
[TBL] [Abstract][Full Text] [Related]
37. Surgical Treatments of Hepatobiliary Cancers.
Gunasekaran G; Bekki Y; Lourdusamy V; Schwartz M
Hepatology; 2021 Jan; 73 Suppl 1():128-136. PubMed ID: 32438491
[TBL] [Abstract][Full Text] [Related]
38. Management of primary hepatopancreatobiliary small cell carcinoma.
Groeschl RT; Christians KK; Turaga KK; Gamblin TC
J Surg Oncol; 2013 Jun; 107(7):692-5. PubMed ID: 23280574
[TBL] [Abstract][Full Text] [Related]
39. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
40. Update on regional treatments for hepatobiliary malignancies.
Curley SA
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1437-52. PubMed ID: 7574729
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
